Value Bridge — MERCYONE WATERLOO MEDICAL CENTER
Current $-14M → Target $-8M (+$6.3M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-14.4M
Current EBITDA
$-8.1M
Target EBITDA
+$6.3M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$1.4M
Payer Mix Optimization
$3.4M
Cost to Collect Reduction
$1.1M
Clean Claim Improvement
$0.8M
Volume & Rate Growth
$5.7M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-14M to $-8M. The highest-impact lever is Volume & Rate Growth at $2.3M probability-weighted.
IC talking point: "We see $6M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $69M in equity value creation."